Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Up to $8,500 · Income ≤600% FPL (COLI-adjusted) · Covers treatment-related co-pays and co-insurance for prescription drugs, labs, scans and tests
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
C85.90 C85.91 C85.92 C85.93 C85.94 C85.95 C85.96 C85.97 C85.98 C85.99 C85.9ADrugs whose J-codes this fund matches. Each links to its billing & coding reference.
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 877-557-2672, and check the alternatives below.
Manufacturer copay programs may also apply — see the drug pages: Rituxan / biosimilars, Gazyva.
Status shown as of each fund's last verification.
As of July 31, 2026, the Blood Cancer United Non-Hodgkin Lymphoma fund is operating a WAITLIST. Call the foundation to confirm current intake. Verify at time of service: 877-557-2672.
Up to $8,500. Covers treatment-related co-pays and co-insurance for prescription drugs, labs, scans and tests
Household income must be ≤600% FPL (COLI-adjusted). US resident.
Accepted: commercial, medicare, medicaid, tricare.
The foundation's published processing time is 3–5 business days. Renewal: annual reapplication.